BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21884408)

  • 21. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
    Tormey CA; Santhanakrishnan M; Smith NH; Liu J; Marschner S; Goodrich RP; Hendrickson JE
    Transfusion; 2016 Apr; 56(4):863-72. PubMed ID: 26643781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model.
    Yu H; Stowell SR; Bernardo L; Hendrickson JE; Zimring JC; Amash A; Uchikawa M; Lazarus AH
    J Immunol; 2014 Sep; 193(6):2902-10. PubMed ID: 25122924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo.
    Strbo N; Yamazaki K; Lee K; Rukavina D; Podack ER
    Am J Reprod Immunol; 2002 Oct; 48(4):220-5. PubMed ID: 12516632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
    Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
    Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients.
    Kwun J; Hu H; Schadde E; Roenneburg D; Sullivan KA; DeMartino J; Burlingham WJ; Knechtle SJ
    J Immunol; 2007 Dec; 179(12):8016-25. PubMed ID: 18056341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.
    Erdmann AA; Jung U; Foley JE; Toda Y; Fowler DH
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):604-13. PubMed ID: 15319772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.
    Shand JC; Qin H; Nasholm N; Capitini CM; Fry TJ
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):26-36. PubMed ID: 24141010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.
    Smith NH; Hod EA; Spitalnik SL; Zimring JC; Hendrickson JE
    Blood; 2012 Feb; 119(6):1566-9. PubMed ID: 22077064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection.
    Gilot BJ; Hara M; Jones ND; van Maurik A; Niimi M; Hadjianastassiou V; Morris PJ; Wood KJ
    Transplantation; 2000 Feb; 69(4):639-48. PubMed ID: 10708123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Frequencies of Anti-Host Reactive CD8+ T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model.
    Gassa A; Kalkavan H; Jian F; Duhan V; Khairnar V; Shaabani N; Honke N; Carpinteiro A; Botezatu L; Crivello P; Dolff S; Ferencik S; Häussinger D; Khandanpour C; Fleischhauer K; Witzke O; Wahlers T; Hardt C; Lang PA; Lang KS
    Cell Physiol Biochem; 2016; 38(4):1343-53. PubMed ID: 27007114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.
    Arthur CM; Patel SR; Smith NH; Bennett A; Kamili NA; Mener A; Gerner-Smidt C; Sullivan HC; Hale JS; Wieland A; Youngblood B; Zimring JC; Hendrickson JE; Stowell SR
    J Immunol; 2017 Apr; 198(7):2671-2680. PubMed ID: 28250159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.
    Hendrickson JE; Chadwick TE; Roback JD; Hillyer CD; Zimring JC
    Blood; 2007 Oct; 110(7):2736-43. PubMed ID: 17591943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.
    Madrid DJ; Santhanakrishnan M; Liu J; Gibb DR; Liu D; Natarajan P; Beitler D; Shi Z; Mo C; Tormey CA; Patel SR; Stowell SR; Hendrickson JE
    Blood Transfus; 2019 Sep; 17(5):368-377. PubMed ID: 30418129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
    McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
    Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning.
    Kim YM; Mapara MY; Down JD; Johnson KW; Boisgerault F; Akiyama Y; Benichou G; Pelot M; Zhao G; Sykes M
    Blood; 2004 Jan; 103(2):732-9. PubMed ID: 14512313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.
    Lamb LS; Szafer F; Henslee-Downey PJ; Walker M; King S; Godder K; Pati AR; Best R; Steinman L; Geier SS
    Exp Hematol; 1995 Dec; 23(14):1595-600. PubMed ID: 8542952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcγ receptors in mice.
    Mener A; Patel SR; Arthur CM; Stowell SR
    Transfusion; 2019 Jan; 59(1):371-384. PubMed ID: 30474857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.